leadf
logo-loader
viewOrocobre Limited
(
ASX:ORE
)

Orocobre wraps up placement to raise $6.25 million

no_picture_pai.jpg

Australian-listed minerals exploration company Orocobre (ASX: ORE) has announced it has completed a placement of 5.68 million shares to institutional investors at an issue price of A$1.10 to raise $6.25 million

The issue price of represents a 5.2% discount to the 10 day volume weighted average price prior to the Company entering into a trading halt and the issue was heavily oversubscribed.

Current and former Directors have collectively exercised 7,000,000 unlisted options at a cost of A$1,750,000.

This was part funded by the sale of 1,250,000 shares at $1.10, 750,000 of which were placed to clients of Patersons Securities Ltd and 500,000 were sold to Lithium Investors LLC, a company associated with Chairman James Calaway.

Quick facts: Orocobre Limited

Follow
ASX:ORE

Price: 8.54 AUD

Market Cap: $5.44 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress

Redx Pharma PLC's (LON:REDX) Lisa Anson joins Proactive London on the same day as the company present research at the European Society for Medical Oncology (ESMO) Congress. The firm presented the data from the phase I trial of its RXC004 monotherapy study which is their lead drug candidate,...

7 hours, 56 minutes ago

2 min read